Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.03.10.532020v1?rss=1

Authors: Vegas, A. D., Madsen, S., Cooke, K. C., Carroll, L., Khor, J. X. Y., Turner, N., Lim, X. Y., Astore, M. A., Morris, J., Don, A. S., Garfield, A., Zarini, S., Zemski Berry, K. A., Ryan, A. P., Bergman, B. C., Brozinick, J. T., James, D. E., Burchfield, J. G.

Abstract:
Insulin resistance (IR) is a complex metabolic disorder that underlies several human diseases, including type 2 diabetes and cardiovascular disease. Despite extensive research, the precise mechanisms underlying IR development remain poorly understood. Here, we provide new insights into the mechanistic connections between cellular alterations associated with IR, including increased ceramides, deficiency of coenzyme Q (CoQ), mitochondrial dysfunction, and oxidative stress. We demonstrate that elevated levels of ceramide in the mitochondria of skeletal muscle cells results in CoQ depletion and loss of mitochondrial respiratory chain components, leading to mitochondrial dysfunction and IR. Further, decreasing mitochondrial ceramide levels in vitro and in animal models increased CoQ levels and was protective against IR. CoQ supplementation also rescued ceramide-associated IR. Examination of the mitochondrial proteome from human muscle biopsies revealed a strong correlation between the respirasome system and mitochondrial ceramide as key determinants of insulin sensitivity. Our findings highlight the mitochondrial Ceramide-CoQ-respiratory chain nexus as a potential foundation of an IR pathway that may also play a critical role in other conditions associated with ceramide accumulation and mitochondrial dysfunction, such as heart failure, cancer, and aging. These insights may have important clinical implications for the development of novel therapeutic strategies for the treatment of IR and related metabolic disorders.

Copy rights belong to original authors. Visit the link for more info

Podcast created by Paper Player, LLC